Showing results (131-140 of 365) with videos related to

Sort By:
Pageof 37
Journal of Clinical Medicine|March 4, 2020
Specialized Management of Oral Anticoagulation Therapy Improves Outcome in Patients with Chronic Renal InsufficiencyMichael Lauterbach, Eduard Uhrich, Lisa Eggebrecht, et al.
Clinical Chemistry and Laboratory Medicine|November 28, 2012
Midregional pro-atrial natriuretic peptide in the general population/Insights from the Gutenberg Health StudyStergios Tzikas, Till Keller, Philipp S Wild, et al.
Plos One|December 11, 2013
Depression in atrial fibrillation in the general populationRenate B Schnabel, Matthias Michal, Sandra Wilde, et al.
American Heart Journal|November 27, 2008
Selenium supplementation improves antioxidant capacity in vitro and in vivo in patients with coronary artery disease The SElenium Therapy in Coronary Artery disease Patients (SETCAP) StudyRenate Schnabel, Edith Lubos, Claudia M Messow, et al.
Progress in Cardiovascular Diseases|June 12, 2025
Heart rate variability in patients with cardiovascular diseasesMuhammad Shahzeb Khan, Syed Sarmad Javaid, Robert J Mentz, et al.
Deutsches Arzteblatt International|December 15, 2022
The Prevalence of Hearing Loss and Provision With Hearing Aids in the Gutenberg Health StudyJulia Döge, Berit Hackenberg, Karoline O Brien, et al.
Translational Vision Science & Technology|September 5, 2020
Peripapillary Retinal Nerve Fiber Layer Profile in Relation to Refractive Error and Axial Length: Results From the Gutenberg Health StudyFelix Mathias Wagner, Esther Maria Hoffmann, Stefan Nickels, et al.
BMC Public Health|November 1, 2022
Protective behavior and SARS-CoV-2 infection risk in the population - Results from the Gutenberg COVID-19 studyRieke Baumkötter, Simge Yilmaz, Daniela Zahn, et al.
Eclinicalmedicine|May 8, 2023
Clinical profile and outcome of isolated pulmonary embolism: a systematic review and meta-analysisVincent Ten Cate, Jürgen H Prochaska, Andreas Schulz, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|January 11, 2020
The relevance of depressive symptoms for the outcome of patients receiving vitamin K antagonists: results from the thrombEVAL cohort studyMatthias Michal, Lisa Eggebrecht, Sebastian Göbel, et al.
Pageof 37